Skip to main content
Premium Trial:

Request an Annual Quote

Harold Ingalls, Morgan Sheng

Premium
Aruna Biomedical announced this week that it has appointed Harold "Bud" Ingalls to its board of directors.
 
Prior to his current role as CFO of Premier Exhibitions, Ingalls served as vice president and chief financial officer at CardioMEMS. From 2001 to 2006, Ingalls served as vice president of finance and chief financial officer of Serologicals. Prior to Serologicals, Ingalls was employed as president and chief financial officer of LaRoche Industries
 

 
Genentech has appointed Morgan Sheng as vice president of neuroscience, effective Sept. 15, the company said this week. In this newly created position, Sheng will be responsible for directing neurobiology drug discovery efforts at Genentech and will oversee the department of neurobiology.
 

Sheng joins Genentech from the Massachusetts Institute of Technology,where he was Menicon Professor of Neuroscience at the Power Institute for Learning and Memory and RIKEN-MIT Neuroscience Research Center in the departments of brain and cognitive science and biology.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.